✦ LIBER ✦

One-year results of a multicenter controlled clinical trial of triamcinolone in pars plana vitrectomy

✍ Scribed by Keita Yamakiri; Taiji Sakamoto; Yoshihiro Noda; Masaaki Nakahara; Nobuchika Ogino; Toshiaki Kubota; Mitsunobu Yokoyama; Mariko Furukawa; Tatsuro Ishibashi

Publisher: Springer-Verlag
Year: 2008
Tongue: English
Weight: 164 KB
Volume: 246
Category: Article
ISSN: 0065-6100
DOI: 10.1007/s00417-008-0829-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Three-year results of a randomized contr

Three-year results of a randomized controlled clinical trial of the posterior composite QuiXfil in class I and II cavities

✍ Juergen Manhart; Hong-Yan Chen; Reinhard Hickel 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 132 KB

Maintenance of infliximab treatment in a

Maintenance of infliximab treatment in ankylosing spondylitis: Results of a one-year randomized controlled trial comparing systematic versus on-demand treatment

✍ Maxime Breban; Philippe Ravaud; Pascal Claudepierre; Gabriel Baron; Yves-Dominiq 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views

The relationship of serum infliximab con

The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: Results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial

✍ E. William St.Clair; Carrie L. Wagner; Adedigbo A. Fasanmade; Benjamin Wang; Tho 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

## Abstract ## Objective To investigate the relationship between serum concentrations of infliximab, a monoclonal anti–tumor necrosis factor α antibody, and clinical improvement from infliximab therapy for rheumatoid arthritis (RA). ## Methods Multiple blood samples were obtained from each of 42

A prospective, randomised controlled tri

A prospective, randomised controlled trial of femoral ring allograft versus a titanium cage in circumferential lumbar spinal fusion with minimum 2-year clinical results

✍ Patrick J. McKenna; Brian J. C. Freeman; Robert C. Mulholland; Michael P. Grevit 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 384 KB

Interferon-α does not improve outcome at

Interferon-α does not improve outcome at one year in patients with diffuse cutaneous scleroderma: Results of a randomized, double-blind, placebo-controlled trial

✍ Carol M. Black; Alan J. Silman; Ariane I. Herrick; Christopher P. Denton; Helen 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 1 views

## Objective: To determine whether interferon-alpha (ifnalpha) reduces the severity of skin involvement in early (<3 years) diffuse scleroderma. ## Methods: In a randomized, placebo-controlled, double-blind trial, 35 patients with early scleroderma received subcutaneous injections of either ifnal

Ultrasonographic and radiographic result

Ultrasonographic and radiographic results from a two-year controlled trial of immediate or one-year–delayed addition of infliximab to ongoing methotrexate therapy in patients with erosive early rheumatoid arthritis

✍ P. C. Taylor; A. Steuer; J. Gruber; C. McClinton; D. O. Cosgrove; M. J. K. Bloml 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 2 views